Progyny, Inc. Operating Lease Right-of-Use Assets
Progyny, Inc. (PGNY) had Operating Lease Right-of-Use Assets of $23.58 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-07
- 2026-06-30: Operating Lease, Right-of-Use Asset $23.58M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $24.27M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $24.99M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $25.68M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $23.58M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $24.27M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $24.99M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $25.68M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $26.42M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $26.95M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $17.25M 10-K · filed 2026-02-27 |
| 2024-09-30 | $17.44M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $17.81M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $17.18M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $17.61M 10-K · filed 2025-03-03 |
| 2023-09-30 | $18.03M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $18.45M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $18.87M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $6.90M 10-K · filed 2024-02-29 |
| 2022-09-30 | $7.13M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $7.36M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $7.58M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $7.80M 10-K · filed 2023-03-01 |
| 2021-09-30 | $8.02M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $8.24M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $8.46M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $8.67M 10-K · filed 2022-03-01 |
| 2020-01-01 | $9.50M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |